<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EFC5F760-3112-4C93-959E-0ABFF0F79190"><gtr:id>EFC5F760-3112-4C93-959E-0ABFF0F79190</gtr:id><gtr:firstName>Christian</gtr:firstName><gtr:surname>Frezza</gtr:surname><gtr:orcidId>0000-0002-3293-7397</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12022%2F6"><gtr:id>78626981-6684-41C6-956D-56CA89F7BBBA</gtr:id><gtr:title>Investigation of the role of metabolism in tumorigenesis</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12022/6</gtr:grantReference><gtr:abstractText>Cancer is currently viewed as a genetic disease whereby well-characterised gene mutations are sufficient to drive unrestrained growth and proliferation. In order to support proliferation, cancer cells utilise a specific set of nutrients, among which glucose and glutamine are the most important. It has been shown that inherent dysfunctions of glucose and glutamine metabolism in some circumstances predispose to cancer formation. However, how altered metabolism drives tumorigenesis in not fully understood.
In this programme, we intend to investigate the role of metabolic genes involved in cancer formation using cell culture and animal models. Our goal is to define how each candidate gene triggers tumorigenesis in vivo and to find metabolic pathways required for the survival of these mutant tumours in order to determine potential anti-cancer drug targets. Furthermore, we aim to detect early signs of these metabolic changes in body fluids such as urine and blood, in order to discover novel biomarkers for the early detection of cancer.</gtr:abstractText><gtr:technicalSummary>In order to proliferate, migrate, and survive under the harsh environmental conditions experienced in solid tumours, cancer cells undergo profound metabolic changes. Oncogenes and tumour suppressor orchestrate this metabolic reprogramming by activating cancer-specific metabolic pathways that optimise nutrients utilisation. The correlation between cancer and altered metabolism is mutual. Indeed, recent evidence suggests that small molecule metabolites accumulated under physio-pathological conditions support and, in some cases, promote cell transformation. These small molecule metabolites, also known as oncometabolites, have been shown to activate oncogenic signalling cascades by impinging on both transcriptional and translational processes in the cell. However, how cancer cells rewire their metabolism and how, in turn, metabolites contribute to tumorigenesis is still unclear. 
Our laboratory uses a multidisciplinary approach to understand the intricacies of cancer metabolism and to elucidate novel mechanisms of tumorigenesis driven by metabolic cues, including nutrient and oxygen availability. In particular, our approach encompasses the use of in vitro and in vitro models of cancer, their metabolic characterisation using metabolomics methods, and systems biology to model the results. We aim to exploit this knowledge to find novel pharmacological targets and to discover cancer biomarkers that can be used for early detection and for assessing disease progression. Our work has multiple implications for health and disease. First, it will improve our understanding of the process of cancer transformation, bringing a novel perspective to the field of oncology. Second, our work will investigate synthetic lethal pathways in cancer cell to find novel pharmacological targets for cancer therapy. Finally, by discovering novel biomarkers of cancer, our work will provide the community with tools for early detection of cancer and for patient stratification.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1740000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Featured article on MRC website</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2A62EC5D-46A1-4804-9870-ED6455432403</gtr:id><gtr:impact>News story based on recent research published on MRC website. Raised awareness of research into the development of the first 3D model of a tumour to study how cancers can survive with low levels of oxygen. Such a tool will reveal more about the inner workings of cancers and help the development of new treatments.</gtr:impact><gtr:outcomeId>56ab9d1760ab00.80327770</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>https://www.mrc.ac.uk/news/browse/3d-tumour-model-replicates-oxygen-starvation-in-cancers/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for Abcam</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9A176A13-3017-463B-A27E-4B1415D5074E</gtr:id><gtr:impact>I was interviewed by a member of Abcam to explain the recent advances in the field of cancer metabolism</gtr:impact><gtr:outcomeId>56cb18e10260c7.23803196</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Featured article in Cambridge News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>95FA810A-6E62-4F34-B7EC-833923FE39CB</gtr:id><gtr:impact>News story based on recent research published in Cambridge News. Raised awareness of research into the development of the first 3D model of a tumour to study how cancers can survive with low levels of oxygen. Such a tool will reveal more about the inner workings of cancers and help the development of new treatments.</gtr:impact><gtr:outcomeId>56af7006078ae6.00281294</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.cambridge-news.co.uk/Cambridge-scientists-create-cancer-model-help/story-28277636-detail/story.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Featured article in MRC Network</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A7060BF2-C6F6-4391-8349-91E512C065E2</gtr:id><gtr:impact>News story based on recent research published in MRC Network. Raised awareness of research into the development of the first 3D model of a tumour to study how cancers can survive with low levels of oxygen. Such a tool will reveal more about the inner workings of cancers and help the development of new treatments.</gtr:impact><gtr:outcomeId>56c7173074ce77.94330027</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>https://www.mrc.ac.uk/publications/browse/network-winter-2015-16/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Participation in MRC Festival of Science Open Day 2016 at MRC CU</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>39588BBF-06B8-4B86-8223-BF9CFC452E55</gtr:id><gtr:impact>60 sixth form Students from 8 schools in Cambridge visited the MRC Cancer Unit on the afternoon of the 22nd Junefor an Open Day. All students, accompanied by their teachers, were given a tour of the enitre building with an opportunity for engaging with researchers about the state of the art in cancer research and gaining hands-on experience with setting up experiments. Talks about career opportunities and challenges associated with pursuing cancer research were also available to all attendees. Sparked a greatd eal of interest and enthusiasm in students and teachers alike and we have had a request for this event to be continued. We will be pursuing a similar format of activities for the MRC Science Festival in 2017, but reach out to more number of schools, including those outside of Cambridge city perimeters.</gtr:impact><gtr:outcomeId>589db500df5de3.59134805</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>https://mrccancerunit.wordpress.com/2016/07/06/inspiring-the-next-generation-of-cancer-researchers-the-mrc-cancer-unit-open-day-2016/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Featured article on University of Cambridge website</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7EB4CCFA-AC15-4367-8C01-4C7857829F4D</gtr:id><gtr:impact>News article of a recent study published on University of Cambridge website. Raised awareness of the research with a wider, public audience. This epigenetics study, carried out in association with collaborators at The Gurdon Institute, uncovered a new type of epigenetic modification. Such a discovery has the potential to open up the field of epigenetics.</gtr:impact><gtr:outcomeId>56af713cb28f90.44687027</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.cam.ac.uk/research/news/epigenetic-discovery-suggests-dna-modifications-more-diverse-than-previously-thought</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Participation in the University of Cambridge Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D68FBE82-51CB-46B7-B5C4-61379A156717</gtr:id><gtr:impact>The Cambridge Science Festival aims to reach out to the general public and communicate about the different aspects of science and research being undertaken at the University. It is a free event, over two weeks, with an excess of 270 events and more than 30000 attendees. As part of this, the MRC CU along with the CRUK CI organised a set of talks and activities that were attended by over 100 people from all walks of life - from young children and young adults to parents/carers and professionals. The Frezza lab was part of the MRC CU team at this event. The event generated a lot of interest in cancer research, helped raise awareness about the importance of 'early' in cancer which is the mission of the MRc CU and also led to a lot of interest being generated in the MRC Festival of Science which followed on later in the year.</gtr:impact><gtr:outcomeId>589dd343f080c3.08609260</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.sciencefestival.cam.ac.uk/events?search_api_views_fulltext=cancer</gtr:url><gtr:year>2013,2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival 2014</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>50BC0363-2742-408F-9AA0-EE97AE4ADAE0</gtr:id><gtr:impact>Discussed research and coordinated activities

Increased awareness of research</gtr:impact><gtr:outcomeId>543e5329e292d1.26476504</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cambridge Cancer Centre Pump Priming Award</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>Cambridge Cancer Centre</gtr:fundingOrg><gtr:id>6994C03D-F635-4096-8E26-F80963784323</gtr:id><gtr:outcomeId>545d2d855a0634.31179571</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>62000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CCC Pump Priming Award</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Cambridge Cancer Centre</gtr:fundingOrg><gtr:id>C0D05067-5230-40DC-A33A-28C01039E80F</gtr:id><gtr:outcomeId>56d5a5764ae8a4.79154637</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>87B146D5-3ABA-4A23-8F52-7790C66E5B01</gtr:id><gtr:title>Exploiting tumour addiction with a serine and glycine-free diet.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>5a85b58070fab9.13325696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E0C6491-3661-40B6-942E-78695EC9C27F</gtr:id><gtr:title>Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf39094ef632ebbb42066741ffd829ea"><gtr:id>cf39094ef632ebbb42066741ffd829ea</gtr:id><gtr:otherNames>Sciacovelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58a1a571c2e2f9.16480948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85F620CE-BDE3-4DBE-9BC1-169B8A09FE0A</gtr:id><gtr:title>Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells.</gtr:title><gtr:parentPublicationTitle>Metabolic engineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b6b97c1cb2f406310f16fad13434597"><gtr:id>5b6b97c1cb2f406310f16fad13434597</gtr:id><gtr:otherNames>Gon?alves E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1096-7176</gtr:issn><gtr:outcomeId>5a85b91e228699.89619379</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAD65DBF-A532-4829-B6AE-3FF083313CB5</gtr:id><gtr:title>Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b194fb2b4c2aca6f8612ef5f9eb99990"><gtr:id>b194fb2b4c2aca6f8612ef5f9eb99990</gtr:id><gtr:otherNames>Chouchani ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>55d2dfc76757f2.87805541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E25918D9-1C9A-4597-99A4-4FDFEEA63717</gtr:id><gtr:title>Fumarate induces redox-dependent senescence by modifying glutathione metabolism.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2adafad2f9a3124ace63cc227abbc312"><gtr:id>2adafad2f9a3124ace63cc227abbc312</gtr:id><gtr:otherNames>Zheng L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>55d2dfc6c68b33.15515585</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44BF7C12-09B4-4E72-8155-9FB1AC4F4D09</gtr:id><gtr:title>The metabolic alterations of cancer cells.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf39094ef632ebbb42066741ffd829ea"><gtr:id>cf39094ef632ebbb42066741ffd829ea</gtr:id><gtr:otherNames>Sciacovelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>5436aa00b1a953.21332258</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D841685D-BE89-4A09-8AF4-23DA2C77E158</gtr:id><gtr:title>Metabolic adaptations to targeted therapy in FLT3 mutated acute myeloid leukaemia</gtr:title><gtr:parentPublicationTitle>LANCET</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3781ec8ef9b063c25c09644a65b213b9"><gtr:id>3781ec8ef9b063c25c09644a65b213b9</gtr:id><gtr:otherNames>Gallipoli Paolo</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5a85b838a8e934.09701543</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E837C0AB-14D3-4BC0-A5C0-98F2E97366AF</gtr:id><gtr:title>Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a71a540bba39918bfdfd516c6f54f977"><gtr:id>a71a540bba39918bfdfd516c6f54f977</gtr:id><gtr:otherNames>Matheson NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>5617c2a7b6f093.62780690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD7CD05F-D156-4E14-B71C-A0BF2A50C773</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>56ab92a7c50bc2.06725030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE9D09B7-235E-4ECB-BD51-755D527ABE03</gtr:id><gtr:title>Editorial: The Metabolic Challenges of Immune Cells in Health and Disease.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b9f929dc02cb31bf9c190aa1d55dcfc"><gtr:id>7b9f929dc02cb31bf9c190aa1d55dcfc</gtr:id><gtr:otherNames>Frezza C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>55d2dfc5d794c8.46195578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31589358-5713-4BDA-BA09-E05F997A49D6</gtr:id><gtr:title>Fumarate Hydratase Loss Causes Combined Respiratory Chain Defects.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf1ac861cd85cabdd250abbe22e327bd"><gtr:id>cf1ac861cd85cabdd250abbe22e327bd</gtr:id><gtr:otherNames>Tyrakis PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a85ba1e3f2da6.38743732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60494C2C-5BF1-4786-9F65-365776F1F989</gtr:id><gtr:title>A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration.</gtr:title><gtr:parentPublicationTitle>Molecular systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2de4c0d76977e46505843f808e6c5494"><gtr:id>2de4c0d76977e46505843f808e6c5494</gtr:id><gtr:otherNames>Yizhak K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1744-4292</gtr:issn><gtr:outcomeId>5436a9ffd36863.73910450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38536348-42CC-4106-B2E5-7C46CF8B861B</gtr:id><gtr:title>Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a17271fe07cec6a3ad6c5b9ee6640b43"><gtr:id>a17271fe07cec6a3ad6c5b9ee6640b43</gtr:id><gtr:otherNames>Gaude E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58a1a65c7b34b4.80708271</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4019CB30-2A75-4B8C-A107-637DC6101F9A</gtr:id><gtr:title>A roadmap for interpreting (13)C metabolite labeling patterns from cells.</gtr:title><gtr:parentPublicationTitle>Current opinion in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/067e4eaa1a86ae8b7fc14ae9aabed987"><gtr:id>067e4eaa1a86ae8b7fc14ae9aabed987</gtr:id><gtr:otherNames>Buescher JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0958-1669</gtr:issn><gtr:outcomeId>55d2dfc65434d0.21586234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6C07E70-9F44-4F50-9B3F-32D475452D2D</gtr:id><gtr:title>Defects in mitochondrial metabolism and cancer.</gtr:title><gtr:parentPublicationTitle>Cancer &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a17271fe07cec6a3ad6c5b9ee6640b43"><gtr:id>a17271fe07cec6a3ad6c5b9ee6640b43</gtr:id><gtr:otherNames>Gaude E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2049-3002</gtr:issn><gtr:outcomeId>5436aa00166502.19445032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8967456-DFBD-4080-9E12-2DA24CCD5E20</gtr:id><gtr:title>Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/776dcdd2c1e165de95f2d978d4b0fa38"><gtr:id>776dcdd2c1e165de95f2d978d4b0fa38</gtr:id><gtr:otherNames>Hilvo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>56ab92a8a42845.01902852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>811B8106-EE68-443C-9F4A-48D462F4D1A4</gtr:id><gtr:title>Succinate Accumulation During Warm and Cold Ischemia in Mouse, Pig and Man: Mechanistic and Therapeutic Implications for Transplant Ischemia-Reperfusion Injury</gtr:title><gtr:parentPublicationTitle>AMERICAN JOURNAL OF TRANSPLANTATION</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cd5e0e599f490c44a91a5ff99e64709"><gtr:id>9cd5e0e599f490c44a91a5ff99e64709</gtr:id><gtr:otherNames>Martin J.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>5a85b62b8f1bb8.10797492</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B065903-0BBA-4994-B651-775B13EA7323</gtr:id><gtr:title>High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebbb6faa1998781fbbe4078c18e07b01"><gtr:id>ebbb6faa1998781fbbe4078c18e07b01</gtr:id><gtr:otherNames>Braicu EI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>5a85b9f48839f9.36273376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D03AA95-0B47-4064-B5AD-7E853BBDD297</gtr:id><gtr:title>Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5eb9958ad6a76e20b7e1d439ad902026"><gtr:id>5eb9958ad6a76e20b7e1d439ad902026</gtr:id><gtr:otherNames>Catanzaro D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>55ed94487ce6f3.51051405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BF72B74-3EEB-44DC-BD95-B97D18DD9C79</gtr:id><gtr:title>High throughput synthetic lethality screen reveals a tumorigenic role of adenylate cyclase in fumarate hydratase-deficient cancer cells.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c340f5b9b59df6b4e65286cefdd9954"><gtr:id>6c340f5b9b59df6b4e65286cefdd9954</gtr:id><gtr:otherNames>Boettcher M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>5436aa0134acb8.66314695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5264180-F2A3-4FFE-A686-B30B39A2A8CF</gtr:id><gtr:title>Mammalian Circadian Period, But Not Phase and Amplitude, Is Robust Against Redox and Metabolic Perturbations.</gtr:title><gtr:parentPublicationTitle>Antioxidants &amp; redox signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26fa57e4e83d8768e58ffbf874f2a03d"><gtr:id>26fa57e4e83d8768e58ffbf874f2a03d</gtr:id><gtr:otherNames>Putker M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1523-0864</gtr:issn><gtr:outcomeId>5a85b551834278.35124488</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2A634F2-05B4-453B-857B-FB3F692FC135</gtr:id><gtr:title>Cancer metabolism: Addicted to serine.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b9f929dc02cb31bf9c190aa1d55dcfc"><gtr:id>7b9f929dc02cb31bf9c190aa1d55dcfc</gtr:id><gtr:otherNames>Frezza C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>58a1a8038e3840.42814614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C706D90-2BEF-4217-BAEF-23F5B6712EE2</gtr:id><gtr:title>Proteomics-based metabolic modeling reveals that fatty acid oxidation (FAO) controls endothelial cell (EC) permeability.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d55f43b8b40349e28ed23380a6aea664"><gtr:id>d55f43b8b40349e28ed23380a6aea664</gtr:id><gtr:otherNames>Patella F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn><gtr:outcomeId>55d2dfc6f3e753.47099981</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>078AEE3F-7D78-411C-A404-8A185CF9D422</gtr:id><gtr:title>Transplanted induced neural stem cells ameliorate experimental autoimmune encephalomyelitis by metabolic reprogramming of mononuclear phagocytes</gtr:title><gtr:parentPublicationTitle>GLIA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8ee7224ac5729e2f56b6ab64d76704c"><gtr:id>c8ee7224ac5729e2f56b6ab64d76704c</gtr:id><gtr:otherNames>Peruzzotti-Jametti L.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>5a85b5aacfd248.34266175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C478B3EF-4050-4116-B993-553C662E4425</gtr:id><gtr:title>Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61de41cef5e0acf82cff59ae4b6ce3a3"><gtr:id>61de41cef5e0acf82cff59ae4b6ce3a3</gtr:id><gtr:otherNames>Allen MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>5436aa01bdf173.08517594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F017AF0C-B938-4637-92E2-600B51BC3F5F</gtr:id><gtr:title>Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abd7a37b9297640ca1acf371bf2dd424"><gtr:id>abd7a37b9297640ca1acf371bf2dd424</gtr:id><gtr:otherNames>Kerr EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d6c0018549d3.47935905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A79360EB-91B2-4F9C-A21E-334480A2EC62</gtr:id><gtr:title>Fumarate drives EMT in renal cancer.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf39094ef632ebbb42066741ffd829ea"><gtr:id>cf39094ef632ebbb42066741ffd829ea</gtr:id><gtr:otherNames>Sciacovelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>58a19b386bc3f2.84367055</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>775AD2C3-EDCC-45B2-AE40-8214272E8373</gtr:id><gtr:title>SUCCINATE ACCUMULATION DURING WARM ISCHAEMIA IS MUCH GREATER THAN COLD ISCHAEMIA IN MOUSE, PIG AND MAN: MECHANISTIC AND THERAPEUTIC IMPLICATIONS FOR TRANSPLANT ISCHAEMIA-REPERFUSION INJURY</gtr:title><gtr:parentPublicationTitle>TRANSPLANT INTERNATIONAL</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78104ec5c46ce7e1bacee41480c52494"><gtr:id>78104ec5c46ce7e1bacee41480c52494</gtr:id><gtr:otherNames>Martin Jack</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0934-0874</gtr:issn><gtr:outcomeId>5a85b45e440672.91920023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEBB0DBF-B2E8-4735-86E6-128C7DB02244</gtr:id><gtr:title>Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf39094ef632ebbb42066741ffd829ea"><gtr:id>cf39094ef632ebbb42066741ffd829ea</gtr:id><gtr:otherNames>Sciacovelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>5a85b9c645b960.82459390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90DF176F-4D17-4CE1-8D68-ED89E7F8D360</gtr:id><gtr:title>Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17e12f0bf7b2d588d26d64444d86df65"><gtr:id>17e12f0bf7b2d588d26d64444d86df65</gtr:id><gtr:otherNames>Zecchini V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>5436aa00ea5c52.52974037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E7AD032-5C61-4798-87DB-737FF760DEE8</gtr:id><gtr:title>METABOLIC ADAPTATIONS TO TARGETED THERAPY IN FLT3 MUTATED ACUTE MYELOID LEUKAEMIA</gtr:title><gtr:parentPublicationTitle>HAEMATOLOGICA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2ce6d961b14401c9de01670680ce1b2"><gtr:id>e2ce6d961b14401c9de01670680ce1b2</gtr:id><gtr:otherNames>Gallipoli P.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>5a85b5109a3f70.13663205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF842DE1-7C54-4364-B170-2D3CD5FFAD8A</gtr:id><gtr:title>A Unifying Mechanism for Mitochondrial Superoxide Production during Ischemia-Reperfusion Injury.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b194fb2b4c2aca6f8612ef5f9eb99990"><gtr:id>b194fb2b4c2aca6f8612ef5f9eb99990</gtr:id><gtr:otherNames>Chouchani ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>56ab92a75da613.57235695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E86AC3FC-7C65-455C-9F80-E27B0C709285</gtr:id><gtr:title>Metabolic Reprogramming and Oncogenesis: One Hallmark, Many Organelles.</gtr:title><gtr:parentPublicationTitle>International review of cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a14d3de722f2895f9500857f36b9e666"><gtr:id>a14d3de722f2895f9500857f36b9e666</gtr:id><gtr:otherNames>Costa ASH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1937-6448</gtr:issn><gtr:outcomeId>5a85b8ad3a2278.67755484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80C87B00-3DD7-4091-AAA3-8409645AC819</gtr:id><gtr:title>A three-dimensional engineered tumour for spatial snapshot analysis of cell metabolism and&amp;nbsp;phenotype in hypoxic gradients.</gtr:title><gtr:parentPublicationTitle>Nature materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aef7aab0b92ca9ae4fafd989ef0a3e6"><gtr:id>6aef7aab0b92ca9ae4fafd989ef0a3e6</gtr:id><gtr:otherNames>Rodenhizer D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1476-1122</gtr:issn><gtr:outcomeId>5655f3b1d8da44.76501713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95C5D638-E88E-4FB4-AE7F-815273A31519</gtr:id><gtr:title>Identification of methylated deoxyadenosines in vertebrates reveals diversity in DNA modifications.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/568924a564e6faa929cb98a8bb8043c4"><gtr:id>568924a564e6faa929cb98a8bb8043c4</gtr:id><gtr:otherNames>Koziol MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>56ab92a8764838.97490930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06E7C213-0993-41F0-BCD7-D6CFAE0A1BC6</gtr:id><gtr:title>Extracellular vesicles are independent metabolic units with asparaginase activity.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50d888fdfcf8107a87022b8abbe1c357"><gtr:id>50d888fdfcf8107a87022b8abbe1c357</gtr:id><gtr:otherNames>Iraci N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>5a85b4b610aa22.96353406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67B2E1EE-2018-4671-87EE-085DEE7DD0AF</gtr:id><gtr:title>Dysregulated metabolism contributes to oncogenesis.</gtr:title><gtr:parentPublicationTitle>Seminars in cancer biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cc11890ba11c0bdc469074b9e210924"><gtr:id>5cc11890ba11c0bdc469074b9e210924</gtr:id><gtr:otherNames>Hirschey MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1044-579X</gtr:issn><gtr:outcomeId>561ccd78d18fa6.44950275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0E0D259-9B55-4417-88C9-574370CDE44D</gtr:id><gtr:title>Metabolic reprograming of mononuclear phagocytes in progressive multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af464df264b306d774d5d2bbdd196c4e"><gtr:id>af464df264b306d774d5d2bbdd196c4e</gtr:id><gtr:otherNames>Tannahill GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>55d2dfc61eb446.49214915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B54D8C3-7BB0-4B6B-8A72-2C5A81274DE2</gtr:id><gtr:title>Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0911bfc22cf8becbc426a0ccadc52d0"><gtr:id>c0911bfc22cf8becbc426a0ccadc52d0</gtr:id><gtr:otherNames>Mills EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>58074e59812fe4.29006422</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A07865AD-4296-455B-9BCD-9C8D0A332C76</gtr:id><gtr:title>Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2de4c0d76977e46505843f808e6c5494"><gtr:id>2de4c0d76977e46505843f808e6c5494</gtr:id><gtr:otherNames>Yizhak K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>55d2dfc735bc89.46947913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE33F0D7-729A-4B9C-881C-2CCEEA948341</gtr:id><gtr:title>Mitochondrial metabolites: undercover signalling molecules.</gtr:title><gtr:parentPublicationTitle>Interface focus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b9f929dc02cb31bf9c190aa1d55dcfc"><gtr:id>7b9f929dc02cb31bf9c190aa1d55dcfc</gtr:id><gtr:otherNames>Frezza C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2042-8898</gtr:issn><gtr:outcomeId>5a85b5e6b072f7.90545196</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5FE444B-7537-44DE-B65C-F26701C84F51</gtr:id><gtr:title>Oncometabolites: Unconventional triggers of oncogenic signalling cascades.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf39094ef632ebbb42066741ffd829ea"><gtr:id>cf39094ef632ebbb42066741ffd829ea</gtr:id><gtr:otherNames>Sciacovelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>58a1a831dff820.88164718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>278F663D-50CB-475B-9DF9-961B9FF6385A</gtr:id><gtr:title>Succinate metabolism: a new therapeutic target for myocardial reperfusion injury.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c99ab515db7fbe217cd8d6dd0b35f97f"><gtr:id>c99ab515db7fbe217cd8d6dd0b35f97f</gtr:id><gtr:otherNames>Pell VR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>58074e59d10729.45359176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17BE88AE-3253-459F-8241-FA62FFAAD51C</gtr:id><gtr:title>Mitochondrial Metabolism: Yin and Yang for Tumor Progression.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99cc01fd1e4f7b98e5c636a5d85f2aa9"><gtr:id>99cc01fd1e4f7b98e5c636a5d85f2aa9</gtr:id><gtr:otherNames>Valcarcel-Jimenez L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>5a85b3e77ddd96.88858835</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88D6516F-EBCD-4D7A-849E-5CD60879F58A</gtr:id><gtr:title>Designing a broad-spectrum integrative approach for cancer prevention and treatment.</gtr:title><gtr:parentPublicationTitle>Seminars in cancer biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7c8a963fb0f2d5b1754c4986046b6f5"><gtr:id>c7c8a963fb0f2d5b1754c4986046b6f5</gtr:id><gtr:otherNames>Block KI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1044-579X</gtr:issn><gtr:outcomeId>5655f3b20c4083.35946598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24C45A02-6FF7-4C68-B7DF-87E2A7313A1E</gtr:id><gtr:title>A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration</gtr:title><gtr:parentPublicationTitle>Molecular Systems Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2de4c0d76977e46505843f808e6c5494"><gtr:id>2de4c0d76977e46505843f808e6c5494</gtr:id><gtr:otherNames>Yizhak K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1744-4292</gtr:issn><gtr:outcomeId>55d2dfc68e16f1.15575998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C871BAF3-477C-473E-8E1D-5230EFA215BF</gtr:id><gtr:title>Mutations in mitochondrial DNA causing tubulointerstitial kidney disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9a445c00d4a496e57ee743091335841"><gtr:id>e9a445c00d4a496e57ee743091335841</gtr:id><gtr:otherNames>Connor TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>5a85b7a211dd81.83328317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0342901-7F22-47EC-AFBE-88EF327FEF66</gtr:id><gtr:title>Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1a Stability in Aerobic Conditions.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fbc4ca8ba5003117f7675215adb2c25"><gtr:id>7fbc4ca8ba5003117f7675215adb2c25</gtr:id><gtr:otherNames>Burr SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>58a1a6260d7e99.03165124</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>431AADEC-D4B6-42BB-8644-3F3E5EF7CFFA</gtr:id><gtr:title>Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells.</gtr:title><gtr:parentPublicationTitle>Cancer &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2adafad2f9a3124ace63cc227abbc312"><gtr:id>2adafad2f9a3124ace63cc227abbc312</gtr:id><gtr:otherNames>Zheng L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2049-3002</gtr:issn><gtr:outcomeId>5436abbc26ba21.78181808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAF98185-2473-4D92-9F1E-DC8C38186CCB</gtr:id><gtr:title>The role of mitochondria in the oncogenic signal transduction.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b9f929dc02cb31bf9c190aa1d55dcfc"><gtr:id>7b9f929dc02cb31bf9c190aa1d55dcfc</gtr:id><gtr:otherNames>Frezza C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>5436aa01808f35.60921906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C24DF46-FC7F-4A0A-831D-64DA5310ECED</gtr:id><gtr:title>Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8&amp;nbsp;T Cells in the Same Host.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76183b379cf986c149f52dd20886bd52"><gtr:id>76183b379cf986c149f52dd20886bd52</gtr:id><gtr:otherNames>Schurich A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58a1a7d6441930.87972795</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>569E22F2-D3E6-4309-9370-CF75435C0920</gtr:id><gtr:title>Germline FH mutations presenting with pheochromocytoma.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1f7a0b056ac1558a2bea8616ac2f14a"><gtr:id>a1f7a0b056ac1558a2bea8616ac2f14a</gtr:id><gtr:otherNames>Clark GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5436aa0047ead9.88087920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29625A92-BDEF-4461-9114-B831F0FFFF6E</gtr:id><gtr:title>Metabolic determinants of the immune modulatory function of neural stem cells.</gtr:title><gtr:parentPublicationTitle>Journal of neuroinflammation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d27b63f32fc7fdad16e23dcc7ae4d54"><gtr:id>2d27b63f32fc7fdad16e23dcc7ae4d54</gtr:id><gtr:otherNames>Drago D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1742-2094</gtr:issn><gtr:outcomeId>58a1a69664c776.40238532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5262A7F-3B04-4993-8123-1B9E4B0A2E10</gtr:id><gtr:title>Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20).</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3d928f330ac931bd645c8362aa905d6"><gtr:id>c3d928f330ac931bd645c8362aa905d6</gtr:id><gtr:otherNames>Burrows N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58a1a8712c4a03.37233736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D589AEA-C854-4AED-9D16-442822D5C8D3</gtr:id><gtr:title>Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7aec26dc8e9b89f9fd14eec6e079fea"><gtr:id>f7aec26dc8e9b89f9fd14eec6e079fea</gtr:id><gtr:otherNames>Gammage PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>58074e59a38d04.66850908</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12022/6</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>